CN1227259C - 用于治疗脂代谢紊乱的与胆汁酸相连的丙醇胺类衍生物 - Google Patents
用于治疗脂代谢紊乱的与胆汁酸相连的丙醇胺类衍生物 Download PDFInfo
- Publication number
- CN1227259C CN1227259C CNB998116343A CN99811634A CN1227259C CN 1227259 C CN1227259 C CN 1227259C CN B998116343 A CNB998116343 A CN B998116343A CN 99811634 A CN99811634 A CN 99811634A CN 1227259 C CN1227259 C CN 1227259C
- Authority
- CN
- China
- Prior art keywords
- compound
- acid
- alkyl
- formula
- links
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
实施例的化合物 | IC 50Na -TCDC[μmol]IC50Na-试验物质[μmol] |
1j | 1.51 |
1k | 1.59 |
2d | 0.56 |
2e | 1.96 |
4 | 0.50 |
7 | 0.15 |
8 | 0.91 |
9 | 2.02 |
10 | 1.63 |
11 | 1.96 |
12 | 2.58 |
13 | 0.56 |
14 | 1.52 |
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19845403.1 | 1998-10-02 | ||
DE19845403A DE19845403B4 (de) | 1998-10-02 | 1998-10-02 | Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1321166A CN1321166A (zh) | 2001-11-07 |
CN1227259C true CN1227259C (zh) | 2005-11-16 |
Family
ID=7883185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB998116343A Expired - Fee Related CN1227259C (zh) | 1998-10-02 | 1999-09-18 | 用于治疗脂代谢紊乱的与胆汁酸相连的丙醇胺类衍生物 |
Country Status (22)
Country | Link |
---|---|
US (1) | US6180618B1 (zh) |
EP (1) | EP1117676B1 (zh) |
JP (1) | JP4598953B2 (zh) |
KR (1) | KR20010075511A (zh) |
CN (1) | CN1227259C (zh) |
AR (1) | AR035003A1 (zh) |
AT (1) | ATE273991T1 (zh) |
AU (1) | AU757366B2 (zh) |
BR (1) | BR9915019A (zh) |
CA (1) | CA2346085A1 (zh) |
DE (2) | DE19845403B4 (zh) |
DK (1) | DK1117676T3 (zh) |
ES (1) | ES2226440T3 (zh) |
HK (1) | HK1040717A1 (zh) |
HU (1) | HUP0103570A3 (zh) |
ID (1) | ID29353A (zh) |
PL (1) | PL347106A1 (zh) |
PT (1) | PT1117676E (zh) |
RU (1) | RU2234512C2 (zh) |
TR (1) | TR200100897T2 (zh) |
WO (1) | WO2000020437A1 (zh) |
ZA (1) | ZA200102586B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053076B2 (en) | 2001-08-29 | 2006-05-30 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
US7161008B2 (en) * | 2002-05-03 | 2007-01-09 | Sanofi - Aventis Deutschland GmbH | Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them |
GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
GB0817969D0 (en) * | 2008-10-01 | 2008-11-05 | Axcess Ltd | Pharmaceutical composition |
US20110294767A1 (en) | 2010-05-26 | 2011-12-01 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
ES2633766T3 (es) | 2011-10-28 | 2017-09-25 | Lumena Pharmaceuticals Llc | Inhibidores de reciclaje de ácido biliar para el tratamiento de enfermedades de hígado colestático pediátrico |
MX363161B (es) | 2011-10-28 | 2019-03-13 | Lumena Pharmaceuticals Inc | Inhibidores de la recirculación de ácidos biliares para el tratamiento de hipercolemia y enfermedad hepática colestásica. |
JP2016514684A (ja) | 2013-03-15 | 2016-05-23 | ルメナ ファーマシューティカルズ エルエルシー | 原発性硬化性胆管炎および炎症性腸疾患の処置のための胆汁酸再循環阻害剤 |
MX2015013196A (es) | 2013-03-15 | 2016-04-15 | Lumena Pharmaceuticals Inc | Inhibidores de reciclaje de acidos biliares para el tratamiento de la enfermedad de reflujo gastroesofagico y esofago de barrett. |
AU2020221834A1 (en) | 2019-02-12 | 2021-09-02 | Mirum Pharmaceuticals, Inc. | Genotype and dose-dependent response to an ASBTI in patients with bile salt export pump deficiency |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI892341A (fi) * | 1988-06-10 | 1989-12-11 | Hoffmann La Roche | Propanolaminderivat. |
GB2250634A (en) * | 1990-12-04 | 1992-06-10 | Marconi Gec Ltd | Point contact diodes |
FI106800B (fi) * | 1990-12-06 | 2001-04-12 | Hoechst Ag | Menetelmä uusien terapeuttisesti käyttökelpoisten dimeeristen sappihappojohdannaisten valmistamiseksi |
JP2616845B2 (ja) * | 1991-02-21 | 1997-06-04 | 清水化学株式会社 | システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤 |
GB9203347D0 (en) * | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
ATE147384T1 (de) * | 1992-02-22 | 1997-01-15 | Hoechst Ag | 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP0624593A3 (de) * | 1993-05-08 | 1995-06-07 | Hoechst Ag | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel. |
TW289021B (zh) * | 1993-05-08 | 1996-10-21 | Hoechst Ag | |
ES2223091T3 (es) * | 1997-04-04 | 2005-02-16 | Aventis Pharma Deutschland Gmbh | Derivados de propanolamina hipolipidemicos. |
-
1998
- 1998-10-02 DE DE19845403A patent/DE19845403B4/de not_active Expired - Fee Related
-
1999
- 1999-09-18 TR TR2001/00897T patent/TR200100897T2/xx unknown
- 1999-09-18 ID IDW20010737A patent/ID29353A/id unknown
- 1999-09-18 PL PL99347106A patent/PL347106A1/xx unknown
- 1999-09-18 WO PCT/EP1999/006930 patent/WO2000020437A1/de not_active Application Discontinuation
- 1999-09-18 JP JP2000574548A patent/JP4598953B2/ja not_active Expired - Fee Related
- 1999-09-18 CN CNB998116343A patent/CN1227259C/zh not_active Expired - Fee Related
- 1999-09-18 RU RU2001111816/04A patent/RU2234512C2/ru not_active IP Right Cessation
- 1999-09-18 EP EP99947385A patent/EP1117676B1/de not_active Expired - Lifetime
- 1999-09-18 PT PT99947385T patent/PT1117676E/pt unknown
- 1999-09-18 DK DK99947385T patent/DK1117676T3/da active
- 1999-09-18 DE DE59910300T patent/DE59910300D1/de not_active Expired - Lifetime
- 1999-09-18 AU AU60855/99A patent/AU757366B2/en not_active Ceased
- 1999-09-18 AT AT99947385T patent/ATE273991T1/de not_active IP Right Cessation
- 1999-09-18 BR BR9915019-0A patent/BR9915019A/pt not_active IP Right Cessation
- 1999-09-18 ES ES99947385T patent/ES2226440T3/es not_active Expired - Lifetime
- 1999-09-18 HU HU0103570A patent/HUP0103570A3/hu unknown
- 1999-09-18 CA CA002346085A patent/CA2346085A1/en not_active Abandoned
- 1999-09-18 KR KR1020017004131A patent/KR20010075511A/ko not_active Application Discontinuation
- 1999-09-29 US US09/408,169 patent/US6180618B1/en not_active Expired - Lifetime
- 1999-09-30 AR ARP990104961A patent/AR035003A1/es unknown
-
2001
- 2001-03-29 ZA ZA200102586A patent/ZA200102586B/en unknown
-
2002
- 2002-03-27 HK HK02102338.5A patent/HK1040717A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US6180618B1 (en) | 2001-01-30 |
RU2234512C2 (ru) | 2004-08-20 |
AR035003A1 (es) | 2004-04-14 |
AU6085599A (en) | 2000-04-26 |
EP1117676B1 (de) | 2004-08-18 |
TR200100897T2 (tr) | 2001-10-22 |
EP1117676A1 (de) | 2001-07-25 |
AU757366B2 (en) | 2003-02-20 |
PL347106A1 (en) | 2002-03-25 |
ATE273991T1 (de) | 2004-09-15 |
ID29353A (id) | 2001-08-23 |
ZA200102586B (en) | 2001-10-03 |
BR9915019A (pt) | 2001-08-14 |
JP4598953B2 (ja) | 2010-12-15 |
HUP0103570A3 (en) | 2003-01-28 |
HK1040717A1 (zh) | 2002-06-21 |
DE19845403A1 (de) | 2000-04-13 |
WO2000020437A1 (de) | 2000-04-13 |
DE19845403B4 (de) | 2005-02-10 |
HUP0103570A2 (hu) | 2002-02-28 |
PT1117676E (pt) | 2004-11-30 |
DK1117676T3 (da) | 2004-12-20 |
DE59910300D1 (de) | 2004-09-23 |
ES2226440T3 (es) | 2005-03-16 |
CN1321166A (zh) | 2001-11-07 |
JP2002526550A (ja) | 2002-08-20 |
CA2346085A1 (en) | 2000-04-13 |
KR20010075511A (ko) | 2001-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1135223C (zh) | 芳基取代的丙醇胺衍生物、包含它们的药物和它们的用途 | |
CN1309711C (zh) | 3-酰氨基-1,2-苯并异噁唑衍生物、其制备方法及应用 | |
CN100338077C (zh) | 康泼瑞素a-4磷酸前体药物单-和双-有机胺盐,单-和双-氨基酸盐,和单-和双-氨基酸酯盐 | |
CN1088456C (zh) | 取代的噁唑烷需钙蛋白酶和/或组织蛋白酶b抑制剂 | |
CN1022630C (zh) | (环烷基胺基)亚甲基双(膦酸)化合物的制备方法 | |
CN1040985C (zh) | 苯并氮杂䓬类化合物的制备方法 | |
CN1524857A (zh) | 一种用作生长激素促分泌素的取代二肽的酒石酸盐 | |
CN1227259C (zh) | 用于治疗脂代谢紊乱的与胆汁酸相连的丙醇胺类衍生物 | |
CN101031306A (zh) | 作为抗hiv剂的核苷膦酸酯缀合物 | |
CN1164192A (zh) | 多相催化蛋白酶的抑制剂 | |
CN1238781A (zh) | 七肽催产素类似物 | |
CN1173951C (zh) | 取代1,3-二芳基-2-吡啶-2-基-3-(吡啶-2-基氨基)-丙醇衍生物、其制备方法、含有它们的药物组合物及其应用 | |
CN1198818C (zh) | 具有释放生长激素特性的化合物 | |
CN1234797A (zh) | N-取代的氮杂环化合物 | |
CN1349524A (zh) | 血管紧张肽原酶抑制剂 | |
CN1066150C (zh) | 作为基质金属蛋白酶抑制剂的桥式吲哚 | |
CN1040211C (zh) | 基质金属蛋白酶抑制剂 | |
CN1127488C (zh) | 具有生长激素释放特性的化合物 | |
CN1798744A (zh) | 作为nmda/nr2b拮抗剂的3-氟-哌啶化合物 | |
CN1151165A (zh) | 三萜衍生物及其药用组合物 | |
CN1221538C (zh) | 1,5-苯并二氮杂䓬衍生物的钙盐、该盐的制备方法及含有该盐的药物 | |
CN100340572C (zh) | 新的lhrh拮抗剂 | |
CN1126738C (zh) | 苯甲酰胺衍生物及含有它们的药物 | |
CN1285828A (zh) | 被含有一个氮原子的五、六或七元杂环取代的咪唑基烷基 | |
CN1282322A (zh) | 1,4-二氮杂环庚烷衍生物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SANOFI- AVENTIS GERMAN CO., LTD. Free format text: FORMER NAME OR ADDRESS: AVENTIS PHARMACY (GERMANY)INTERNATIONAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Frankfurt, Germany Patentee after: Hoechst Marion Roussel de GmbH Address before: Frankfurt, Germany Patentee before: Awentis Medicines Deutschland GmbH |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1040717 Country of ref document: HK |